BLUELINX HOLDINGS INC (BXC) Stock Fundamental Analysis

NYSE:BXC • US09624H2085

65.92 USD
-2.15 (-3.16%)
At close: Feb 27, 2026
65.9154 USD
0 (-0.01%)
After Hours: 2/27/2026, 8:04:00 PM
Fundamental Rating

4

Overall BXC gets a fundamental rating of 4 out of 10. We evaluated BXC against 50 industry peers in the Trading Companies & Distributors industry. The financial health of BXC is average, but there are quite some concerns on its profitability. BXC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • BXC had positive earnings in the past year.
  • In the past year BXC had a positive cash flow from operations.
  • Of the past 5 years BXC 4 years were profitable.
  • BXC had a positive operating cash flow in 4 of the past 5 years.
BXC Yearly Net Income VS EBIT VS OCF VS FCFBXC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

1.2 Ratios

  • BXC's Return On Assets of 0.89% is on the low side compared to the rest of the industry. BXC is outperformed by 62.00% of its industry peers.
  • BXC has a worse Return On Equity (2.25%) than 62.00% of its industry peers.
  • BXC's Return On Invested Capital of 2.26% is on the low side compared to the rest of the industry. BXC is outperformed by 66.00% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for BXC is in line with the industry average of 9.54%.
  • The 3 year average ROIC (11.49%) for BXC is well above the current ROIC(2.26%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 0.89%
ROE 2.25%
ROIC 2.26%
ROA(3y)8.8%
ROA(5y)11.32%
ROE(3y)22.02%
ROE(5y)56.9%
ROIC(3y)11.49%
ROIC(5y)14.44%
BXC Yearly ROA, ROE, ROICBXC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300

1.3 Margins

  • BXC has a worse Profit Margin (0.48%) than 62.00% of its industry peers.
  • In the last couple of years the Profit Margin of BXC has declined.
  • The Operating Margin of BXC (1.53%) is worse than 68.00% of its industry peers.
  • BXC's Operating Margin has improved in the last couple of years.
  • BXC has a worse Gross Margin (15.34%) than 84.00% of its industry peers.
  • In the last couple of years the Gross Margin of BXC has grown nicely.
Industry RankSector Rank
OM 1.53%
PM (TTM) 0.48%
GM 15.34%
OM growth 3Y-33.48%
OM growth 5Y28.68%
PM growth 3Y-36.19%
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y4.13%
BXC Yearly Profit, Operating, Gross MarginsBXC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

6

2. Health

2.1 Basic Checks

  • BXC has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • There is no outstanding debt for BXC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BXC Yearly Shares OutstandingBXC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
BXC Yearly Total Debt VS Total AssetsBXC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 3.40 indicates that BXC is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.40, BXC is in the better half of the industry, outperforming 62.00% of the companies in the same industry.
  • BXC has a Debt/Equity ratio of 0.96. This is a neutral value indicating BXC is somewhat dependend on debt financing.
  • BXC has a Debt to Equity ratio of 0.96. This is comparable to the rest of the industry: BXC outperforms 44.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF N/A
Altman-Z 3.4
ROIC/WACC0.25
WACC9.11%
BXC Yearly LT Debt VS Equity VS FCFBXC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

  • BXC has a Current Ratio of 4.60. This indicates that BXC is financially healthy and has no problem in meeting its short term obligations.
  • BXC has a better Current ratio (4.60) than 90.00% of its industry peers.
  • A Quick Ratio of 3.15 indicates that BXC has no problem at all paying its short term obligations.
  • BXC's Quick ratio of 3.15 is amongst the best of the industry. BXC outperforms 90.00% of its industry peers.
Industry RankSector Rank
Current Ratio 4.6
Quick Ratio 3.15
BXC Yearly Current Assets VS Current LiabilitesBXC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

3

3. Growth

3.1 Past

  • The earnings per share for BXC have decreased strongly by -85.11% in the last year.
  • BXC shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -35.32% yearly.
EPS 1Y (TTM)-85.11%
EPS 3Y-68.55%
EPS 5Y-35.32%
EPS Q2Q%-177.05%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%0.73%

3.2 Future

  • BXC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 78.14% yearly.
  • Based on estimates for the next years, BXC will show a small growth in Revenue. The Revenue will grow by 5.28% on average per year.
EPS Next Y99.87%
EPS Next 2Y78.14%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.06%
Revenue Next 2Y5.28%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BXC Yearly Revenue VS EstimatesBXC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
BXC Yearly EPS VS EstimatesBXC Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 20 30

3

4. Valuation

4.1 Price/Earnings Ratio

  • BXC is valuated quite expensively with a Price/Earnings ratio of 69.39.
  • Based on the Price/Earnings ratio, BXC is valued a bit more expensive than the industry average as 66.00% of the companies are valued more cheaply.
  • BXC's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.07.
  • Based on the Price/Forward Earnings ratio of 34.72, the valuation of BXC can be described as expensive.
  • BXC's Price/Forward Earnings is on the same level as the industry average.
  • When comparing the Price/Forward Earnings ratio of BXC to the average of the S&P500 Index (28.05), we can say BXC is valued slightly more expensively.
Industry RankSector Rank
PE 69.39
Fwd PE 34.72
BXC Price Earnings VS Forward Price EarningsBXC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • 84.00% of the companies in the same industry are more expensive than BXC, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.47
BXC Per share dataBXC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 200 300

4.3 Compensation for Growth

  • BXC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • BXC's earnings are expected to grow with 78.14% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.69
PEG (5Y)N/A
EPS Next 2Y78.14%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • No dividends for BXC!.
Industry RankSector Rank
Dividend Yield 0%

BLUELINX HOLDINGS INC

NYSE:BXC (2/27/2026, 8:04:00 PM)

After market: 65.9154 0 (-0.01%)

65.92

-2.15 (-3.16%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)02-24
Earnings (Next)04-27
Inst Owners99.25%
Inst Owner Change1.62%
Ins Owners2.22%
Ins Owner Change0.01%
Market Cap518.79M
Revenue(TTM)N/A
Net Income(TTM)14.04M
Analysts77.5
Price Target78.03 (18.37%)
Short Float %6.87%
Short Ratio5.51
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-23.92%
Min EPS beat(2)-24.67%
Max EPS beat(2)-23.18%
EPS beat(4)2
Avg EPS beat(4)-7.71%
Min EPS beat(4)-24.67%
Max EPS beat(4)16.15%
EPS beat(8)5
Avg EPS beat(8)19.7%
EPS beat(12)7
Avg EPS beat(12)12.15%
EPS beat(16)11
Avg EPS beat(16)19.22%
Revenue beat(2)0
Avg Revenue beat(2)-1.65%
Min Revenue beat(2)-2.07%
Max Revenue beat(2)-1.23%
Revenue beat(4)1
Avg Revenue beat(4)-1.13%
Min Revenue beat(4)-2.07%
Max Revenue beat(4)0.42%
Revenue beat(8)2
Avg Revenue beat(8)-1.77%
Revenue beat(12)2
Avg Revenue beat(12)-3.86%
Revenue beat(16)5
Avg Revenue beat(16)-0.75%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.05%
EPS NY rev (1m)0%
EPS NY rev (3m)-28.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.24%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.9%
Valuation
Industry RankSector Rank
PE 69.39
Fwd PE 34.72
P/S 0.18
P/FCF N/A
P/OCF 31.08
P/B 0.83
P/tB 0.95
EV/EBITDA 8.47
EPS(TTM)0.95
EY1.44%
EPS(NY)1.9
Fwd EY2.88%
FCF(TTM)-3.19
FCFYN/A
OCF(TTM)2.12
OCFY3.22%
SpS374.69
BVpS79.16
TBVpS69.08
PEG (NY)0.69
PEG (5Y)N/A
Graham Number41.14
Profitability
Industry RankSector Rank
ROA 0.89%
ROE 2.25%
ROCE 3.36%
ROIC 2.26%
ROICexc 3.32%
ROICexgc 3.63%
OM 1.53%
PM (TTM) 0.48%
GM 15.34%
FCFM N/A
ROA(3y)8.8%
ROA(5y)11.32%
ROE(3y)22.02%
ROE(5y)56.9%
ROIC(3y)11.49%
ROIC(5y)14.44%
ROICexc(3y)16.25%
ROICexc(5y)17.76%
ROICexgc(3y)18%
ROICexgc(5y)19.38%
ROCE(3y)17.1%
ROCE(5y)21.48%
ROICexgc growth 3Y-37.08%
ROICexgc growth 5Y30.14%
ROICexc growth 3Y-37.9%
ROICexc growth 5Y30.02%
OM growth 3Y-33.48%
OM growth 5Y28.68%
PM growth 3Y-36.19%
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y4.13%
F-Score6
Asset Turnover1.86
Health
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF N/A
Debt/EBITDA 7.16
Cap/Depr 108.51%
Cap/Sales 1.42%
Interest Coverage 0.97
Cash Conversion 19.98%
Profit Quality N/A
Current Ratio 4.6
Quick Ratio 3.15
Altman-Z 3.4
F-Score6
WACC9.11%
ROIC/WACC0.25
Cap/Depr(3y)106.72%
Cap/Depr(5y)76.81%
Cap/Sales(3y)1.01%
Cap/Sales(5y)0.7%
Profit Quality(3y)260.74%
Profit Quality(5y)177.95%
High Growth Momentum
Growth
EPS 1Y (TTM)-85.11%
EPS 3Y-68.55%
EPS 5Y-35.32%
EPS Q2Q%-177.05%
EPS Next Y99.87%
EPS Next 2Y78.14%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%0.73%
Revenue Next Year3.06%
Revenue Next 2Y5.28%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-56.32%
EBIT growth 3Y-41.21%
EBIT growth 5Y31.62%
EBIT Next Year-8.46%
EBIT Next 3Y8.68%
EBIT Next 5YN/A
FCF growth 1Y-107.18%
FCF growth 3Y-29.86%
FCF growth 5YN/A
OCF growth 1Y-95.66%
OCF growth 3Y-16.25%
OCF growth 5YN/A

BLUELINX HOLDINGS INC / BXC FAQ

What is the fundamental rating for BXC stock?

ChartMill assigns a fundamental rating of 4 / 10 to BXC.


What is the valuation status of BLUELINX HOLDINGS INC (BXC) stock?

ChartMill assigns a valuation rating of 3 / 10 to BLUELINX HOLDINGS INC (BXC). This can be considered as Overvalued.


What is the profitability of BXC stock?

BLUELINX HOLDINGS INC (BXC) has a profitability rating of 3 / 10.


How financially healthy is BLUELINX HOLDINGS INC?

The financial health rating of BLUELINX HOLDINGS INC (BXC) is 6 / 10.